cell therapy manufacturing

cell therapy manufacturing

featured image of Cutting Costs: Unlocking Access to Gene Therapies

Cutting Costs: Unlocking Access to Gene Therapies

BIOT

Excerpt: 📉 High production costs limit access to cell and gene therapies. VIVEbiotech aims for cheaper processes and improved manufacturing! 🧬🔄

featured image of 2025: Game-Changing Trends in Gene Therapy!

2025: Game-Changing Trends in Gene Therapy!

BIOT

Discover the future of cell and gene therapy! 🌟 Innovations in manufacturing, safety, and CAR T-cells are transforming treatment options. 🧬✨

featured image of 2025: Breakthroughs and Challenges in Gene Therapy

2025: Breakthroughs and Challenges in Gene Therapy

BIOT

🚀 Discover the future of cell and gene therapy in 2025! 🌟 Exciting advances, ongoing trials, and a free summit await! 💉📅🎉

featured image of Unlocking Quality: The Secret of Starting Materials

Unlocking Quality: The Secret of Starting Materials

BIOT

Starting materials shape cell therapy quality! 🌱 Learn from Charles River Laboratories about managing variability and ensuring consistency. 🧬🔬❄️

featured image of Unlocking Success: Tackling Cell Therapy Challenges

Unlocking Success: Tackling Cell Therapy Challenges

BIOT

🌱 Overcoming cell therapy challenges: tackle batch variability, improve manufacturing processes, and embrace innovations for better quality and compliance! 🔬📊💡

featured image of Revolutionizing Gene Therapy: Fast-Tracking Innovations!

Revolutionizing Gene Therapy: Fast-Tracking Innovations!

BIOT

Unlocking the future of medicine! 🌟 Innovative gene editing and functional genomics are revolutionizing cell and gene therapy development. 🚀🔬💡

featured image of Ireland's Power Duo Tackles Biopharma Bottlenecks!

Ireland’s Power Duo Tackles Biopharma Bottlenecks!

BIOT

🌟 Ireland's SSPC and NIBRT unite to tackle biopharma bottlenecks! 🔍 Focusing on R&D enhancements and productivity solutions. 🏭 A game-changer!

featured image of Lonza Doubles Capacity Adds 200 Jobs in Switzerland!

Lonza Doubles Capacity Adds 200 Jobs in Switzerland!

BIOT

Lonza expands its Visp facility with two new bioconjugation suites, creating 200 jobs and doubling capacity for antibody-drug conjugates! 🌍🏗️💼📈🌱

featured image of Unlocking AI in Cell Therapy: Start Small for Success!

Unlocking AI in Cell Therapy: Start Small for Success!

BIOT

Cell therapy developers must embrace AI cautiously. 🧬 Start small for gradual growth, ensuring long-term success and better ROI! 📈🤖

featured image of Revolutionizing Viral Vector Production for Advanced Therapies!

Revolutionizing Viral Vector Production for Advanced Therapies!

BIOT

Unlock advanced therapies in gene treatments! 🌟 Overcome manufacturing challenges with Cytiva's ELEVECTA™. 💡 Collaboration is key! 🛠️ HealthcareInnovation

1238 Next